Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorPrograma d'Harmonització Farmacoterapèutica
dc.date.accessioned2022-03-04T11:10:53Z
dc.date.available2022-03-04T11:10:53Z
dc.date.issued2022
dc.identifier.citationPrograma d'Harmonització Farmacoterapèutica. Tractament de la psoriasi en plaques: informe d'avaluació de resultats. Barcelona: Servei Català de la Salut; 2022.
dc.identifier.urihttp://hdl.handle.net/11351/7116
dc.descriptionPsoriasis; Biological treatments; Apremilast
dc.description.abstractThis report selected the data of patients with moderate to severe plaque psoriasis treated with adalimumab, apremilast, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, tildrakizumab, risankizumab, secukinumab and ustekinumab public use of Catalonia (SISCAT) and that they were included in the CatSalut register of patients and treatments (RPT) from 2015. In this period, 6,800 treatments have been used to treat 4,860 patients diagnosed with plaque psoriasis. , who had an average age of 50 years and of whom 58% were men. The initial criteria set out in the Agreement have been met in 4,775 (70.2%) treatments (1st line [52%] and 2nd line and subsequent [91%]). The response rate for first-line treatments was 80.7% and for second-line treatments 77.5%. Overall, the response rate for biologic drugs was 80%, while that of aprililast was 10% lower.
dc.language.isocat
dc.publisherServei Català de la Salut
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectPsoriasi - Tractament
dc.subjectAvaluació de resultats (Assistència sanitària)
dc.subject.meshPsoriasis
dc.subject.mesh/drug therapy
dc.subject.meshDrug Evaluation
dc.titleTractament de la psoriasi en plaques: informe d'avaluació de resultats
dc.typeinfo:eu-repo/semantics/report
dc.subject.decspsoriasis
dc.subject.decs/farmacoterapia
dc.subject.decsevaluación de medicamentos
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record